Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edward Wang

Orthopaedic Surgery East Setauket, NY Medical Doctor

NPI 1942247838 CMS profile 224165

14 Technology Dr, East Setauket, NY 11733

Open in the dashboard

General payments

$9,709

29 records reported · program years 2019–2025

Research payments

$10,500

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$179,916 paid to institutions, not to them · program years 2020–2023

Through program year 2025, Edward Wang of East Setauket, NY is reported in the CMS Open Payments database as having received $9,709 across 29 general payments and $10,500 in research payments paid to them. Separately, studies naming them as principal investigator received $179,916 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 80th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $54 2
2024 General $207 5
2023 General $118 4
2022 General $61 3
2022 Research $600 1
2021 General $61 4
2020 General $5,510 7
2020 Research $7,500 3
2019 General $3,698 4
2019 Research $2,400 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edward Wang
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Edward Wang were reported at $54. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Edward Wang Orthopaedic Surgery median Middle half National median
2019 $3,698 $644 $140–$2,844 $163
2020 $5,510 $312 $75–$1,860 $114
2021 $61 $520 $117–$2,495 $132
2022 $61 $598 $128–$2,731 $149
2023 $118 $461 $128–$2,264 $160
2024 $207 $497 $134–$2,475 $164
2025 $54 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Endo Pharmaceuticals Inc. $5,609 13 payments
  2. Integrity Implants Inc $3,662 2 payments
  3. Stryker Corporation $218 5 payments
  4. Ferring Pharmaceuticals Inc. $87 4 payments
  5. Heron Therapeutics, Inc. $53 1 payment
  6. Zimmer Biomet Holdings, Inc. $40 2 payments
  7. Horizon Therapeutics plc $21 1 payment
  8. Medtronic, Inc. $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $5,280 1 payment
  2. Travel and Lodging $3,662 2 payments
  3. Food and Beverage $592 21 payments
  4. Education $175 5 payments
Products named General payments · program years 2019–2025
  1. XIAFLEX Orthopedic $5,510 7 payments
  2. FlareHawk $3,662 2 payments
  3. SPINEJACK $167 2 payments
  4. XIAFLEX Orthopedic $99 6 payments
  5. EUFLEXXA $87 4 payments
  6. ZYNRELEF $53 1 payment
  7. AEQUALIS PERFORM $37 2 payments
  8. Comprehensive Reverse $26 1 payment
  9. Comprehensive Anatomic $26 1 payment
  10. PENNSAID $21 1 payment
  11. Other $48 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Endo Pharmaceuticals Inc. $10,500 5 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

16

Median for Hand Surgery: 118

Drug cost

$84

Median for Hand Surgery: $615

Branded share of claims

0%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 16 $84

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 85 billing codes

Paid by Medicare

$437,159

Of which drugs: $3,129

Medicare patients

899

Average age 74

Services billed

3,420

550 women, 349 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 38%
Diabetes 30%
Osteoporosis 23%
Depression 21%
Cancer 19%
Chronic kidney disease 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 307 727 $560

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

34 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record